Polyrizon Shares Jump After NASARIX Clears Biocompatibility Benchmarks
Polyrizon Ltd. (NASDAQ:PLRZ) reported that its NASARIX Allergy Blocker nasal spray passed a comprehensive biocompatibility evaluation, with all biological safety endpoints meeting predetermined acceptance criteria. The company said the testing program followed internationally recognized standards and regulatory guidance, and that the results suppor…